Sinovac Biotech Ltd.
Sinovac Biotech Ltd., a prominent player in the biopharmaceutical industry, is headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacture, and commercialisation of vaccines, particularly in the fields of infectious diseases. Sinovac's core products include its inactivated vaccines for hepatitis A, hepatitis B, and influenza, which are distinguished by their rigorous safety and efficacy standards. With a strong presence in Asia and expanding operations globally, Sinovac has achieved significant milestones, including the development of its COVID-19 vaccine, CoronaVac, which has been pivotal in various vaccination campaigns worldwide. The company’s commitment to innovation and public health has solidified its market position, making it a trusted name in vaccine production and distribution.
DitchCarbon Score
How does Sinovac Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinovac Biotech Ltd.'s score of 15 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinovac Biotech Ltd.'s reported carbon emissions
Sinovac Biotech Ltd., headquartered in China (CN), currently does not have available carbon emissions data, as no specific emissions figures have been reported. The company has not established any formal reduction targets or commitments towards achieving net-zero emissions. In the broader context of climate commitments, it is essential for companies in the biotechnology sector to actively engage in sustainability initiatives and set measurable targets to reduce their carbon footprint. While Sinovac Biotech Ltd. has not publicly outlined specific climate strategies or reduction goals, the industry is increasingly focusing on transparency and accountability in emissions reporting. As the global emphasis on climate action intensifies, it is crucial for Sinovac Biotech Ltd. to consider developing and communicating clear carbon reduction strategies to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sinovac Biotech Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
